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Pain perception is subject to powerful modulatory influ-
ences that can increase or reduce subjective responses
in the short and long term. Nociceptive circuits can
become sensitised causing both innocuous and noxious
inputs to be amplified and their intensity and other sen-
sory characteristics to be increased. Both central and
peripheral mechanisms of sensitisation are recognised.
Nociceptive mechanisms are immature at birth, under-
going both structural and functional change during nor-
mal development that can have important consequences
for the maintenance, management and prognosis of
chronic pain in children.
The neurophysiology of pain in children will be briefly
described with special reference to sensitisation in the
context of non-inflammatory musculoskeletal pain and
pain amplification syndromes. A mechanisms based
approach to the medical management of chronic pain in




1Anaesthesia and Pain Medicine, Great Ormond St Hospital For Children,
London, UK. 2UCL Paediatric Pain Research Group, University College
London, London, UK.
Published: 5 December 2013
doi:10.1186/1546-0096-11-S2-I35
Cite this article as: Howard: PReS13-SPK-1575: Science of pain
amplification. Pediatric Rheumatology 2013 11(Suppl 2):I35.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Anaesthesia and Pain Medicine, Great Ormond St Hospital For Children,
London, UK
Full list of author information is available at the end of the article
Howard Pediatric Rheumatology 2013, 11(Suppl 2):I35
http://www.ped-rheum.com/content/11/S2/I35
© 2013 Howard; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
